Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published
Guidance, NICE advice and quality standards
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Filter by title or keyword
Filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (11)
Type
Type
Guidance (1851)
NICE advice (323)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (224)
COVID-19 rapid guidelines (3)
Diagnostics guidance (47)
Health technology evaluations (18)
Highly specialised technologies guidance (27)
Interventional procedures guidance (598)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (340)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (754)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (255)
Apply filters
Showing 41 to 50 of 2372
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Talazoparib for treating HER2-negative advanced breast cancer with germline BRCA mutations
TA952
21 February 2024
21 February 2024
Tuberculosis
NG33
13 January 2016
16 February 2024
Digitally enabled therapies for adults with depression: early value assessment
HTE8
16 May 2023
12 February 2024
Belumosudil for treating chronic graft-versus-host disease after 2 or more systemic treatments in people 12 years and over
TA949
7 February 2024
7 February 2024
Nivolumab–relatlimab for untreated unresectable or metastatic melanoma in people 12 years and over
TA950
7 February 2024
7 February 2024
Olaparib with abiraterone for untreated hormone-relapsed metastatic prostate cancer
TA951
7 February 2024
7 February 2024
Loncastuximab tesirine for treating relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma after 2 or more systemic treatments
TA947
31 January 2024
31 January 2024
Ivosidenib for treating advanced cholangiocarcinoma with an IDH1 R132 mutation after 1 or more systemic treatments
TA948
31 January 2024
31 January 2024
Treosulfan with fludarabine before allogeneic stem cell transplant for people aged 1 month to 17 years with non-malignant diseases (terminated appraisal)
TA945
30 January 2024
30 January 2024
Caesarean birth
NG192
31 March 2021
30 January 2024
Previous page
1
…
3
4
Current page
5
6
7
…
238
Page
5
of
238
Next page
Results per page
10
25
50
All
Back to top